Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study for Patients Who Completed GENA-05 (NuProtect)- to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

NCT01992549 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT01992549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01992549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study for Patients Who Completed GENA-05 (NuProtect)- to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII
Lead sponsor
Octapharma
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
December 27, 2018
Enrollment
48 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

severe hemophilia a